Impact of Initial Discordant Treatment With β-Lactam Antibiotics on Clinical Outcomes in Adults With Pneumococcal Pneumonia: A Systematic Review

The initial discordant treatment with β-lactam antibiotics was not associated with a statistically significant increase in mortality or clinical or bacteriological failure of therapy for pneumococcal pneumonia.